These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3084758)

  • 1. Relative bioavailability of two spray formulations of nitroglycerin.
    Sanders SW; Michaelis K; Maurette JM; Jaeger H
    J Pharm Sci; 1986 Mar; 75(3):244-6. PubMed ID: 3084758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incomplete and delayed bioavailability of sublingual nitroglycerin.
    Noonan PK; Benet LZ
    Am J Cardiol; 1985 Jan; 55(1):184-7. PubMed ID: 3917598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bioavailability of glycerol trinitrate (nitroglycerin) from an ointment preparation].
    Gielsdorf W; Schlegel E; Settlage JA; Jaeger H; Fink E
    Arzneimittelforschung; 1983; 33(12):1677-9. PubMed ID: 6421295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative bioavailability of a new transdermal nitroglycerin delivery system.
    Noonan PK; Gonzalez MA; Ruggirello D; Tomlinson J; Babcock-Atkinson E; Ray M; Golub A; Cohen A
    J Pharm Sci; 1986 Jul; 75(7):688-91. PubMed ID: 3093667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of two nitroglycerin dosage forms: a metered spray and a soft gelatin capsule.
    Erb R; Stoltman W
    J Pharmacokinet Biopharm; 1983 Dec; 11(6):611-21. PubMed ID: 6431075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the bioavailability of glyceryl trinitrate after sublingual administration of spray and tablet.
    Jensen KM; Mikkelsen S
    Arzneimittelforschung; 1997 Jun; 47(6):716-8. PubMed ID: 9239449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biopharmaceutical evaluation of methylcellulose as an excipient for nitroglycerin tablets.
    Shibuya F; Kuramoto K; Koizumi H; Uehara N; Nakagawa F; Tamura Z; Murayama M; Kawakubo K; Kawahara T; Ohshiro M
    J Pharmacobiodyn; 1985 May; 8(5):352-6. PubMed ID: 3930694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioaequivalence of sublingual glycerol trinitrate. Bioavailability and haemodynamic effects after application of a fluorochlorohydrocarbons-dependent spray and a new pumping system.
    Huber T; Merz PG; Harder S; Rietbrock N
    Arzneimittelforschung; 1990 Dec; 40(12):1319-22. PubMed ID: 2128865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the method of application on pharmacokinetics of nitroglycerin from ointment in humans.
    Sved S; McLean WM; McGilveray IJ
    J Pharm Sci; 1981 Dec; 70(12):1368-9. PubMed ID: 6798193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of the bioavailability of nitroglycerin from a transdermal therapeutic system (Nitroderm TTS).
    Imhof PR; Vuillemin T; Gérardin A; Racine A; Müller P; Follath F
    Eur J Clin Pharmacol; 1984; 27(1):7-12. PubMed ID: 6436032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics and relative bioavailability of a nitroglycerin ointment formulation (author's transl)].
    Maier-Lenz H; Ringwelski L; Windorfer A
    Arzneimittelforschung; 1980; 30(2):320-4. PubMed ID: 6769443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of nitroglycerin after parenteral and oral dosing in the rat.
    Fung HL; Ogata H; Kamiya A; Maier GA
    J Pharm Sci; 1984 Jul; 73(7):873-9. PubMed ID: 6432996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitroglycerin absorption from transdermal systems: formulation effects and metabolite concentrations.
    Williams RL; Thakker KM; John V; Lin ET; Liang-Gee W; Benet LZ
    Pharm Res; 1991 Jun; 8(6):744-9. PubMed ID: 1905809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic bioavailability of fluticasone propionate administered as nasal drops and aqueous nasal spray formulations.
    Daley-Yates PT; Baker RC
    Br J Clin Pharmacol; 2001 Jan; 51(1):103-5. PubMed ID: 11167672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and bioavailability of intravenous and topical nitroglycerin in the rhesus monkey: estimate of percutaneous first-pass metabolism.
    Wester RC; Noonan PK; Smeach S; Kosobud L
    J Pharm Sci; 1983 Jul; 72(7):745-8. PubMed ID: 6411893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dose and ointment application technique on nitroglycerin plasma concentrations.
    Iafrate RP; Yost RL; Curry SH; Gotz VP; Caranasos GJ
    Pharmacotherapy; 1983; 3(2 Pt 1):118-24. PubMed ID: 6406987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bioavailability of oral nitroglycerin.
    Noonan PK; Benet LZ
    J Pharm Sci; 1986 Mar; 75(3):241-3. PubMed ID: 3084757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability and pharmacokinetics of a new isosorbide dinitrate spray preparation in healthy volunteers.
    Hutt V; Theodor R; Pabst G; Lutz D; Bonn R; Fritschi E
    Arzneimittelforschung; 1993 Aug; 43(8):842-6. PubMed ID: 8216439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitroglycerin concentration in plasma: comparison between transdermal therapeutic system and ointment.
    Chu LC; Gale RM; Schmitt LG; Shaw JE
    Angiology; 1984 Sep; 35(9):545-52. PubMed ID: 6435484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intranasal administration of nitroglycerin solution and nitroglycerin spray during general anesthesia].
    Iwasaka H; Kunisaki Y; Yamamoto H; Kitano T; Kinoshita R; Taniguchi K; Honda N
    Masui; 1993 Oct; 42(10):1423-8. PubMed ID: 8230691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.